Reducing patient radiation exposure during paediatric SVT ablations: Use of CARTO® 3 in concert with "ALARA" principles profoundly lowers total dose

Robert H. Pass, Gregory J. Gates, Laura A. Gellis, Lynn Nappo, Scott R. Ceresnak

Research output: Contribution to journalArticle

16 Citations (Scopus)

Abstract

Background: "ALARA - As Low As Reasonably Achievable" protocols reduce patient radiation dose. Addition of electroanatomical mapping may further reduce dose. Methods: From 6/11 to 4/12, a novel ALARA protocol was utilised for all patients undergoing supraventricular tachycardia ablation, including low frame rates (2-3 frames/second), low fluoro dose/frame (6-18 nGy/frame), and other techniques to reduce fluoroscopy (ALARA). From 6/12 to 3/13, use of CARTO® 3 (C3) with "fast anatomical mapping" (ALARA+C3) was added to the ALARA protocol. Intravascular echo was not utilised. Demographics, procedural, and radiation data were analysed and compared between the two protocols. Results: A total of 75 patients were included: 42 ALARA patients, and 33 ALARA+C3 patients. Patient demographics were similar between the two groups. The acute success rate in ALARA was 95%, and 100% in ALARA+C3; no catheterisation-related complications were observed. Procedural time was 125.7 minutes in the ALARA group versus 131.4 in ALARA+C3 (p=0.36). Radiation doses were significantly lower in the ALARA+C3 group with a mean air Kerma in ALARA+C3 of 13.1±28.3 mGy (SD) compared with 93.8±112 mGy in ALARA (p<0.001). Mean dose area product was 92.2±179 uGym2 in ALARA+C3 compared with 584±687 uGym2 in ALARA (p<0.001). Of the 33 subjects (42%) in the ALARA+C3 group, 14 received ≤1 mGy exposure. The ALARA+C3 dosages are the lowest reported for a combined electroanatomical-fluoroscopy technique. Conclusions: Addition of CARTO® 3 to ALARA protocols markedly reduced radiation exposure to young people undergoing supraventricular tachycardia ablation while allowing for equivalent procedural efficacy and safety.

Original languageEnglish (US)
Pages (from-to)963-968
Number of pages6
JournalCardiology in the Young
Volume25
Issue number5
DOIs
StatePublished - Jun 10 2014

Fingerprint

Pediatrics
Supraventricular Tachycardia
Fluoroscopy
Radiation
Demography
Catheterization
Radiation Exposure
Air
Safety

Keywords

  • ablation
  • Paediatric
  • radiation
  • supraventricular tachycardia

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine
  • Pediatrics, Perinatology, and Child Health

Cite this

Reducing patient radiation exposure during paediatric SVT ablations : Use of CARTO® 3 in concert with "ALARA" principles profoundly lowers total dose. / Pass, Robert H.; Gates, Gregory J.; Gellis, Laura A.; Nappo, Lynn; Ceresnak, Scott R.

In: Cardiology in the Young, Vol. 25, No. 5, 10.06.2014, p. 963-968.

Research output: Contribution to journalArticle

@article{170fc3c1a7cd4a3ea4021c53e952dc4a,
title = "Reducing patient radiation exposure during paediatric SVT ablations: Use of CARTO{\circledR} 3 in concert with {"}ALARA{"} principles profoundly lowers total dose",
abstract = "Background: {"}ALARA - As Low As Reasonably Achievable{"} protocols reduce patient radiation dose. Addition of electroanatomical mapping may further reduce dose. Methods: From 6/11 to 4/12, a novel ALARA protocol was utilised for all patients undergoing supraventricular tachycardia ablation, including low frame rates (2-3 frames/second), low fluoro dose/frame (6-18 nGy/frame), and other techniques to reduce fluoroscopy (ALARA). From 6/12 to 3/13, use of CARTO{\circledR} 3 (C3) with {"}fast anatomical mapping{"} (ALARA+C3) was added to the ALARA protocol. Intravascular echo was not utilised. Demographics, procedural, and radiation data were analysed and compared between the two protocols. Results: A total of 75 patients were included: 42 ALARA patients, and 33 ALARA+C3 patients. Patient demographics were similar between the two groups. The acute success rate in ALARA was 95{\%}, and 100{\%} in ALARA+C3; no catheterisation-related complications were observed. Procedural time was 125.7 minutes in the ALARA group versus 131.4 in ALARA+C3 (p=0.36). Radiation doses were significantly lower in the ALARA+C3 group with a mean air Kerma in ALARA+C3 of 13.1±28.3 mGy (SD) compared with 93.8±112 mGy in ALARA (p<0.001). Mean dose area product was 92.2±179 uGym2 in ALARA+C3 compared with 584±687 uGym2 in ALARA (p<0.001). Of the 33 subjects (42{\%}) in the ALARA+C3 group, 14 received ≤1 mGy exposure. The ALARA+C3 dosages are the lowest reported for a combined electroanatomical-fluoroscopy technique. Conclusions: Addition of CARTO{\circledR} 3 to ALARA protocols markedly reduced radiation exposure to young people undergoing supraventricular tachycardia ablation while allowing for equivalent procedural efficacy and safety.",
keywords = "ablation, Paediatric, radiation, supraventricular tachycardia",
author = "Pass, {Robert H.} and Gates, {Gregory J.} and Gellis, {Laura A.} and Lynn Nappo and Ceresnak, {Scott R.}",
year = "2014",
month = "6",
day = "10",
doi = "10.1017/S1047951114001474",
language = "English (US)",
volume = "25",
pages = "963--968",
journal = "Cardiology in the Young",
issn = "1047-9511",
publisher = "Cambridge University Press",
number = "5",

}

TY - JOUR

T1 - Reducing patient radiation exposure during paediatric SVT ablations

T2 - Use of CARTO® 3 in concert with "ALARA" principles profoundly lowers total dose

AU - Pass, Robert H.

AU - Gates, Gregory J.

AU - Gellis, Laura A.

AU - Nappo, Lynn

AU - Ceresnak, Scott R.

PY - 2014/6/10

Y1 - 2014/6/10

N2 - Background: "ALARA - As Low As Reasonably Achievable" protocols reduce patient radiation dose. Addition of electroanatomical mapping may further reduce dose. Methods: From 6/11 to 4/12, a novel ALARA protocol was utilised for all patients undergoing supraventricular tachycardia ablation, including low frame rates (2-3 frames/second), low fluoro dose/frame (6-18 nGy/frame), and other techniques to reduce fluoroscopy (ALARA). From 6/12 to 3/13, use of CARTO® 3 (C3) with "fast anatomical mapping" (ALARA+C3) was added to the ALARA protocol. Intravascular echo was not utilised. Demographics, procedural, and radiation data were analysed and compared between the two protocols. Results: A total of 75 patients were included: 42 ALARA patients, and 33 ALARA+C3 patients. Patient demographics were similar between the two groups. The acute success rate in ALARA was 95%, and 100% in ALARA+C3; no catheterisation-related complications were observed. Procedural time was 125.7 minutes in the ALARA group versus 131.4 in ALARA+C3 (p=0.36). Radiation doses were significantly lower in the ALARA+C3 group with a mean air Kerma in ALARA+C3 of 13.1±28.3 mGy (SD) compared with 93.8±112 mGy in ALARA (p<0.001). Mean dose area product was 92.2±179 uGym2 in ALARA+C3 compared with 584±687 uGym2 in ALARA (p<0.001). Of the 33 subjects (42%) in the ALARA+C3 group, 14 received ≤1 mGy exposure. The ALARA+C3 dosages are the lowest reported for a combined electroanatomical-fluoroscopy technique. Conclusions: Addition of CARTO® 3 to ALARA protocols markedly reduced radiation exposure to young people undergoing supraventricular tachycardia ablation while allowing for equivalent procedural efficacy and safety.

AB - Background: "ALARA - As Low As Reasonably Achievable" protocols reduce patient radiation dose. Addition of electroanatomical mapping may further reduce dose. Methods: From 6/11 to 4/12, a novel ALARA protocol was utilised for all patients undergoing supraventricular tachycardia ablation, including low frame rates (2-3 frames/second), low fluoro dose/frame (6-18 nGy/frame), and other techniques to reduce fluoroscopy (ALARA). From 6/12 to 3/13, use of CARTO® 3 (C3) with "fast anatomical mapping" (ALARA+C3) was added to the ALARA protocol. Intravascular echo was not utilised. Demographics, procedural, and radiation data were analysed and compared between the two protocols. Results: A total of 75 patients were included: 42 ALARA patients, and 33 ALARA+C3 patients. Patient demographics were similar between the two groups. The acute success rate in ALARA was 95%, and 100% in ALARA+C3; no catheterisation-related complications were observed. Procedural time was 125.7 minutes in the ALARA group versus 131.4 in ALARA+C3 (p=0.36). Radiation doses were significantly lower in the ALARA+C3 group with a mean air Kerma in ALARA+C3 of 13.1±28.3 mGy (SD) compared with 93.8±112 mGy in ALARA (p<0.001). Mean dose area product was 92.2±179 uGym2 in ALARA+C3 compared with 584±687 uGym2 in ALARA (p<0.001). Of the 33 subjects (42%) in the ALARA+C3 group, 14 received ≤1 mGy exposure. The ALARA+C3 dosages are the lowest reported for a combined electroanatomical-fluoroscopy technique. Conclusions: Addition of CARTO® 3 to ALARA protocols markedly reduced radiation exposure to young people undergoing supraventricular tachycardia ablation while allowing for equivalent procedural efficacy and safety.

KW - ablation

KW - Paediatric

KW - radiation

KW - supraventricular tachycardia

UR - http://www.scopus.com/inward/record.url?scp=84932095643&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84932095643&partnerID=8YFLogxK

U2 - 10.1017/S1047951114001474

DO - 10.1017/S1047951114001474

M3 - Article

C2 - 25155609

AN - SCOPUS:84932095643

VL - 25

SP - 963

EP - 968

JO - Cardiology in the Young

JF - Cardiology in the Young

SN - 1047-9511

IS - 5

ER -